Consonance Capital Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-2,455,114
| Closed | -$18.2M | – | 29 |
|
|
2018
Q4 | $18.2M | Sell |
2,455,114
-11,057,844
| -82% | -$81.8M | 1.34% | 17 |
|
|
2018
Q3 | $73.1M | Buy |
13,512,958
+936,956
| +7% | +$5.07M | 3.94% | 12 |
|
|
2018
Q2 | $44.6M | Hold |
12,576,002
| – | – | 2.88% | 15 |
|
|
2018
Q1 | $25.8M | Buy |
12,576,002
+5,510,082
| +78% | +$11.3M | 2.36% | 17 |
|
|
2017
Q4 | $18.7M | Buy |
7,065,920
+164,492
| +2% | +$434K | 1.68% | 15 |
|
|
2017
Q3 | $36.2M | Buy |
6,901,428
+3,068,715
| +80% | +$16.1M | 4.01% | 12 |
|
|
2017
Q2 | $13.6M | Buy |
+3,832,713
| New | +$13.6M | 1.61% | 14 |
|
|
2016
Q3 | – | Sell |
-1,114,448
| Closed | -$7.84M | – | 26 |
|
|
2016
Q2 | $7.84M | Sell |
1,114,448
-3,403,069
| -75% | -$23.9M | 1.11% | 16 |
|
|
2016
Q1 | $38.4M | Sell |
4,517,517
-981,195
| -18% | -$8.34M | 5.81% | 8 |
|
|
2015
Q4 | $72.2M | Sell |
5,498,712
-759,149
| -12% | -$9.97M | 9.68% | 4 |
|
|
2015
Q3 | $22.9M | Buy |
6,257,861
+859,000
| +16% | +$3.14M | 3.22% | 10 |
|
|
2015
Q2 | $31.1M | Buy |
5,398,861
+3,395,890
| +170% | +$19.6M | 3.12% | 11 |
|
|
2015
Q1 | $11.7M | Buy |
+2,002,971
| New | +$11.7M | 1.07% | 20 |
|